Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28770415 | 0.89 | THRB (0.34) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL10385058 | 0.86 | KDM4E (0.44) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL2153635 | 0.82 | PTPN1 (0.40) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL3102739 | 0.81 | THRB (0.40) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL27666953 | 0.81 | CYP1A2 (0.36) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL10609671 | 0.81 | THRB (0.39) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL330418 | 0.81 | HSD17B10 (0.35) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL29489300 | 0.81 | HSD17B10 (0.35) | HSD17B10KDM4EL3MBTL1ALDH1A1HPGD | |
| SCHEMBL3100065 | 0.80 | TSHR (0.41) | HSD17B10KDM4EALDH1A1TSHRKMT2A | |
| SCHEMBL3157120 | 0.80 | L3MBTL1 (0.42) | L3MBTL1ALDH1A1ELANETSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100384895-C | Actinic-energy-ray-curable composition for optical material | TOAGOSEI CO LTD (JP) | 2008-04-30 | — | — | CN | claimed |
| US-7799844-B2 | Active energy beam-curable composition for optical material | TOAGOSEI CO., LTD. (JP) | 2010-09-21 | — | — | US | disclosed |
| US-7754781-B2 | Active energy beam-curable composition | TOAGOSEI CO., LTD. (JP) | 2010-07-13 | — | — | US | disclosed |
| CN-100551934-C | The composition of active energy ray-curable | TOAGOSEI CO LTD (JP) | 2009-10-21 | — | — | CN | disclosed |
| US-20080227885-A1 | Active Energy Beam-Curable Composition for Optical Material | TOAGOSEI CO., LTD. (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080194727-A1 | Active Energy Beam-Curable Composition | TOAGOSEI CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080145545-A1 | METAL OXIDE AND SULFUR-CONTAINING COATING COMPOSITIONS, METHODS OF USE, AND ARTICLES PREPARED THEREFROM | CITIBANK, N.A., AS COLLATERAL AGENT | 2008-06-19 | — | — | US | disclosed |
| CN-100384895-C | Actinic-energy-ray-curable composition for optical material | TOAGOSEI CO LTD (JP) | 2008-04-30 | — | — | CN | disclosed |
| CN-101128490-A | Active energy ray-curable composition | TOAGOSEI CO LTD (JP) | 2008-02-20 | — | — | CN | disclosed |
| EP-1857469-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2007-11-21 | — | — | EP | disclosed |
| US-7271283-B2 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2007-09-18 | — | — | US | disclosed |
| US-20070043143-A1 | Active energy beam-curable composition for optical material | THOMSON LICENSING (FR) | 2007-02-22 | — | — | US | disclosed |
| CN-1875041-A | Actinic-energy-ray-curable composition for optical material | TOAGOSEI CO LTD (JP) | 2006-12-06 | — | — | CN | disclosed |
| EP-1512704-A1 | High refractive index, UV-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY (US) | 2005-03-09 | — | — | EP | disclosed |
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | GENERAL ELECTRIC COMPANY | 2005-03-03 | — | — | US | disclosed |
| EP-0735062-B1 | ACTINIC-RADIATION-CURABLE COMPOSITION AND LENS SHEET | MITSUBISHI RAYON CO (JP) | 2002-01-30 | — | — | EP | disclosed |
| US-6206550-B1 | BACKLIGHT WITH LENS PORTION MADE FROM A CURABLE COMPOSITION WHICH INCLUDES A BIS(4-(METH)ACRYLOYL-THIOPHENYL) SULFIDE AND (METH)ACRYLATES; HIGH BRIGHTNESS-ENHANCING EFFECT ON LENSES OF PROJECTION TVS AND STEREOSCOPIC PHOTOGRAPHY. | MITSUBISHI RAYON COMPANY LTD. (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-0952466-A2 | Lens sheet | MITSUBISHI RAYON CO., LTD. (JP) | 1999-10-27 | — | — | EP | disclosed |
| US-5969867-A | ACRYLIC ESTERS | MITSUBISHI RAYON COMPANY LTD. (JP) | 1999-10-19 | — | — | US | disclosed |
| EP-0735062-A1 | ACTINIC-RADIATION-CURABLE COMPOSITION AND LENS SHEET | MITSUBISHI RAYON CO., LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050049376-A1 | High refractive index, uv-curable monomers and coating compositions prepared therefrom | MACF1, WASF2, THEM6 | HSD17B10 4113/4885KDM4E 3417/4885L3MBTL1 4467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.